Showing 161-170 of 516 results for "".
News
https://practicalneurology.com/columns/practice-management/news/30622/- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31223/CPT 2007 Updates Impact Neurology PracticesThe 2007 update to the Current Procedural Terminology (CPT) manual introduces several significant changes pertinent to neurology practices, as outlined by Mary H. McDermott in Practical Neurology. While the overall modifications affecting neurology are limi
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0407-painmngmt-pdf/31193/Chronic Pain Management: Addressing Potential Bias in Clinical AssessmentsChronic pain remains a significant challenge in neurology, often complicated by the subjective nature of pain assessment. In the article "Are You Guilty of Bias When Encountering Unexplained Pain?" by Charles Argoff, MD, publi
Establishing Our Foundation of LGMD2I/R9: Unlocking the Genetics
https://practicalneurology.com/programs/cme/establishing-our-foundation-of-lgmd2ir9-unlocking-the-genetics/35877/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Beyond the Symptoms: The True Impact of gMG on Patients' Lives
https://practicalneurology.com/programs/cme/beyond-the-symptoms-the-true-impact-of-gmg-on-patients-lives/32235/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Precision Medicine in Myasthenia Gravis: Crafting Personalized Treatment Strategies
https://practicalneurology.com/programs/cme/precision-medicine-in-myasthenia-gravis-crafting-personalized-treatment-strategies/32244/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.FcRn Antagonists in Myasthenia Gravis: A New Era in Targeted Therapy
https://practicalneurology.com/programs/cme/fcrn-antagonists-in-myasthenia-gravis-a-new-era-in-targeted-therapy/32242/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Integrating Perspectives: The Value of Patient and Caregiver Input
https://mededonthego.com/programs/cme/integrating-perspectives-the-value-of-patient-and-caregiver-input/35883/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Bridging Gaps in LGMD Care
https://mededonthego.com/programs/cme/bridging-gaps-in-lgmd-care/35884/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Diagnosing gMG: Navigating Current Tools and Approaches
https://practicalneurology.com/programs/cme/diagnosing-gmg-navigating-current-tools-and-approaches/32238/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.